| P2093 | author name string | Ali Ahmed | |
| P2860 | cites work | Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials | Q28175861 |
| | Effect of combined aspirin and angiotensin-converting enzyme inhibitor therapy versus angiotensin-converting enzyme inhibitor therapy alone on readmission rates in heart failure | Q28175906 |
| | Aspirin and angiotensin-converting enzyme inhibitors among elderly survivors of hospitalization for an acute myocardial infarction | Q28177216 |
| | Aspirin and the treatment of heart failure in the elderly | Q28177229 |
| | The angiotensin-converting enzyme inhibitor and aspirin interaction in congestive heart failure: fear or reality? | Q28181924 |
| | Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group | Q29619460 |
| | Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients | Q29619542 |
| | Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-conve | Q30597068 |
| | Angiotensin II receptor antagonists | Q33851581 |
| | Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. | Q33895894 |
| | Rationale for the use of combination angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapy in heart failure | Q34019449 |
| | The coxibs, selective inhibitors of cyclooxygenase-2. | Q34086325 |
| | Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) | Q40906958 |
| | Additive Effects of Combined Angiotensin-Converting Enzyme Inhibition and Angiotensin II Antagonism on Blood Pressure and Renin Release in Sodium-Depleted Normotensives | Q41679821 |
| | Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure | Q43569493 |
| | Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function | Q43710362 |
| | An overview of the 4 randomized trials of aspirin therapy in the primary prevention of vascular disease | Q50131542 |
| | NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. | Q50885532 |
| | Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial. | Q50908731 |
| | Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease | Q56944813 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart failure | Q181754 |
| | aspirin | Q18216 |
| P304 | page(s) | 1293-6 | |
| P577 | publication date | 2002-07-01 | |
| P1433 | published in | Journal of the American Geriatrics Society | Q6296094 |
| P1476 | title | Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure? | |
| P478 | volume | 50 | |